Bioequivalence Study of Favipiravir 200 mg Film Tablet (World Medicine, Turkey) Under Fasting Conditions

NCT04407000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Test: Favipiravir 200 mg (LOQULAR)
DRUG: Reference: Favipiravir 200 mg (Avigan)

Sponsor

World Medicine ILAC SAN. ve TIC. A.S.

Collaborators

[object Object]
[object Object]